Banque Cantonale Vaudoise Sorrento Therapeutics, Inc. Transaction History

Banque Cantonale Vaudoise

  • $2.52 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022
SELL
$1.51 - $2.88 $15,100 - $28,800
-10,000 Reduced 66.67%
5,000 $8,000
Q4 2021

Feb 14, 2022
SELL
$4.65 - $7.23 $10,230 - $15,906
-2,200 Reduced 12.79%
15,000 $70,000
Q2 2021

Aug 11, 2021
BUY
$6.35 - $10.0 $3,175 - $5,000
500 Added 2.99%
17,200 $166,000
Q3 2020

Oct 30, 2020
BUY
$6.17 - $18.82 $103,039 - $314,294
16,700 New
16,700 $186,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.48M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email